January 13, 2022 After a record year, where next for biopharma flotations? 2021 was a huge year for IPOs, with pure-play developers raising $14bn, but 2022 is likely to tell a different story.
January 07, 2021 Covid or not, venture financing breaks records Private biotechs attracted more venture cash in 2020 than in any other year of the current cycle.